Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-23T13:54:34.070Z Has data issue: false hasContentIssue false

Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapine

Published online by Cambridge University Press:  16 April 2020

V. Molina*
Affiliation:
Department of Psychiatry, Hospital Clínico Universitario de Salamanca, Paseo de San Vicente, 58–182, 37007Salamanca, Spain Institute for Neuroscience of Castilla y León, Spain
D.E. López
Affiliation:
Institute for Neuroscience of Castilla y León, Spain
R. Villa
Affiliation:
Department of Psychiatry, Hospital Clínico Universitario de Salamanca, Paseo de San Vicente, 58–182, 37007Salamanca, Spain
J. Pérez
Affiliation:
Department of Psychiatry, Hospital Clínico Universitario de Salamanca, Paseo de San Vicente, 58–182, 37007Salamanca, Spain
C. Martín
Affiliation:
Department of Psychiatry, Hospital Clínico Universitario de Salamanca, Paseo de San Vicente, 58–182, 37007Salamanca, Spain
A. Ballesteros
Affiliation:
Department of Psychiatry, Hospital Clínico Universitario de Salamanca, Paseo de San Vicente, 58–182, 37007Salamanca, Spain
A. Cardoso
Affiliation:
Institute for Neuroscience of Castilla y León, Spain
C. Sancho
Affiliation:
Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain
*
*Corresponding author. Fax: +34 923 291448. E-mail address: vmolina@usal.es (V. Molina).
Get access

Abstract

Purpose

To study the short-term effect of treatment with quetiapine on prepulse inhibition (PPI) deficits of the startle reflex in schizophrenia patients.

Subjects and methods

Using PPI, we studied a group of 21 schizophrenia patients and 16 controls. Seventeen of the patients were re-tested with PPI after 21 days of treatment with quetiapine.

Results

At baseline, an almost significant decrease in PPI was found in the patients as compared to the controls. PPI measurements did not change in the patients after 21 days of treatment with quetiapine, despite their clinical improvement.

Conclusion

Our results suggest that short-term quetiapine treatment may not modify PPI measures in schizophrenia patients.

Type
Original article
Copyright
Copyright © Elsevier Masson SAS 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adler, L.E., Olincy, A., Cawthra, E.M., McRae, K.A., Harris, J.G., Nagamoto, H.T., et al.Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 2004; 161: 18221828CrossRefGoogle ScholarPubMed
Auclair, A.L., Galinier, A., Besnard, J., Newman-Tancredi, A., Depoortere, R.Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmacology (Berl) 2007; 193: 4554CrossRefGoogle ScholarPubMed
Bakshi, V.P., Swerdlow, N.R., Braff, D.L., Geyer, M.A.Reversal of isolation rearing-induced deficits in prepulse inhibition by seroquel and olanzapine. Biol Psychiatry 1998; 43: 436445CrossRefGoogle ScholarPubMed
Braff, D.L., Geyer, M.A.Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990; 47: 181188CrossRefGoogle ScholarPubMed
Duncan, E., Madonick, S., Chakravorty, S., Parwani, A., Szilagyi, S., Efferen, T., et al.Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology (Berl) 2001; 156: 266272CrossRefGoogle ScholarPubMed
Ellwanger, J., Geyer, M.A., Braff, D.L.The relationship of age to prepulse inhibition and habituation of the acoustic startle response. Biol Psychol 2003; 62: 175195CrossRefGoogle ScholarPubMed
Filion, D.L., Dawson, M.E., Schell, A.M.The psychological significance of human startle eyeblink modification: a review. Biol Psychol 1998; 47: 143CrossRefGoogle ScholarPubMed
Geyer, M.A., Braff, D.L.Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 1987; 13: 643668CrossRefGoogle ScholarPubMed
Geyer, M.A., Krebs-Thomson, K., Braff, D.L., Swerdlow, N.R.Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001; 156: 117154CrossRefGoogle Scholar
Hamm, A.O., Weike, A.I., Schupp, H.T.The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology (Berl) 2001; 156: 259265CrossRefGoogle ScholarPubMed
Hill, K., Mann, L., Laws, K.R., Stephenson, C.M., Nimmo-Smith, I., McKenna, P.J.Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand 2004; 110: 243256CrossRefGoogle ScholarPubMed
Hollingshead, A., Frederick, R.Social stratification and psychiatric disorders. Am Soc Rev 1953; 18: 163189CrossRefGoogle Scholar
Honea, R., Crow, T.J., Passingham, D., Mackay, C.E.Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162: 22332245CrossRefGoogle ScholarPubMed
Jovanovic, T., Szilagyi, S., Chakravorty, S., Fiallos, A.M., Lewison, B.J., Parwani, A., et al.Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 2004; 41: 401406CrossRefGoogle ScholarPubMed
Kapur, S., Zipursky, R., Jones, C., Shammi, C.S., Remington, G., Seeman, P.A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 2000; 57: 553559CrossRefGoogle ScholarPubMed
Kay, S.R., Fiszbein, A., Opler, L.A.The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261276CrossRefGoogle Scholar
Kumari, V., Soni, W., Sharma, T.Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 1999; 156: 10461051Google ScholarPubMed
Kumari, V., Soni, W., Mathew, V.M., Sharma, T.Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry 2000; 57: 609614CrossRefGoogle ScholarPubMed
Kumari, V., Gray, J.A., Geyer, M.A., ffytche, D., Soni, W., Mitterschiffthaler, M.T., et al.Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 2003; 122: 99113CrossRefGoogle ScholarPubMed
Kumari, V., Gray, J.A., Guptaa, P., Luscher, S., Sharma, T.Sex differences in prepulse inhibition of the acoustic startle response. Personal Individ Differ 2003; 35: 733742CrossRefGoogle Scholar
Kumari, V., Aasen, I., Sharma, T.Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res 2004; 69: 219235CrossRefGoogle ScholarPubMed
Kumari, V., Aasen, I., Papadopoulos, A., Bojang, F., Poon, L., Halari, R., et al.A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men. Neuropsychopharmacology 2008; 33: 26102618CrossRefGoogle ScholarPubMed
Leumann, L., Feldon, J., Vollenweider, F.X., Ludewig, K.Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry 2002; 52: 729739CrossRefGoogle ScholarPubMed
Mackeprang, T., Kristiansen, K.T., Glenthoj, B.Y.Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol Psychiatry 2002; 52: 863873CrossRefGoogle ScholarPubMed
Oranje, B., Van Oel, C.J., Gispen-De Wied, C.C., Verbaten, M.N., Kahn, R.S.Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol 2002; 22: 359365CrossRefGoogle ScholarPubMed
Postma, P., Gray, J.A., Sharma, T., Geyer, M., Mehrotra, R., Das, M., et al.A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) 2006; 184: 589599CrossRefGoogle ScholarPubMed
Powell, S.B., Young, J.W., Ong, J.C., Caron, M.G., Geyer, M.A.Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol 2008; 19: 562565CrossRefGoogle ScholarPubMed
Quednow, B.B., Wagner, M., Westheide, J., Beckmann, K., Bliesener, N., Maier, W., et al.Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol Psychiatry 2006; 59: 536545CrossRefGoogle ScholarPubMed
Quednow, B.B., Wagner, M., Mossner, R., Maier, W., Kuhn, K.U.Sensorimotor gating of schizophrenia patients depends on catechol O-Methyltransferase Val158Met polymorphism. Schizophr Bull 2008; 36: 341346CrossRefGoogle ScholarPubMed
Shoemaker, J.M., Pitcher, L., Noh, H.R., Swerdlow, N.R.Quetiapine produces a prolonged reversal of the sensorimotor gating-disruptive effects of basolateral amygdala lesions in rats. Behav Neurosci 2003; 117: 136143CrossRefGoogle ScholarPubMed
Swerdlow, N.R., Braff, D.L., Geyer, M.A.GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res 1990; 532: 146150CrossRefGoogle ScholarPubMed
Swerdlow, N.R., Bakshi, V., Geyer, M.A.Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 1996; 279: 12901299Google ScholarPubMed
Swerdlow, N.R., Hartman, P.L., Auerbach, P.P.Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 1997; 41: 452460CrossRefGoogle ScholarPubMed
Swerdlow, N.R., Bakshi, V., Waikar, M., Taaid, N., Geyer, M.A.Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology (Berl) 1998; 140: 7580CrossRefGoogle ScholarPubMed
Swerdlow, N.R., Braff, D.L., Geyer, M.A.Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000; 11: 185204CrossRefGoogle Scholar
Swerdlow, N.R., Light, G.A., Cadenhead, K.S., Sprock, J., Hsieh, M.H., Braff, D.L.Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 2006; 63: 13251335CrossRefGoogle Scholar
Swerdlow, N.R., Talledo, J., Sutherland, A.N., Nagy, D., Shoemaker, J.M.Antipsychotic effects on prepulse inhibition in normal ‘low gating’ humans and rats. Neuropsychopharmacology 2006; 31: 20112021CrossRefGoogle ScholarPubMed
Swerdlow, N.R., Sprock, J., Light, G.A., Cadenhead, K., Calkins, M.E., Dobie, D.J., et al.Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res 2007; 92: 237251CrossRefGoogle Scholar
Wynn, J.K., Green, M.F., Sprock, J., Light, G.A., Widmark, C., Reist, C., et al.Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res 2007; 95: 134142CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.